Trial Profile
Evaluate Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Mar 2017
Price :
$35
*
At a glance
- Drugs Gosogliptin (Primary) ; Metformin; Vildagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors SatRx
- 23 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.